STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2453 by analyst upside · 2026-06-27
IQV
IQVIA Holdings Inc.
Healthcare · Market Cap $32B · P/E 23.7x
ANALYST PRICE TARGET
+18.0%
implied upside to consensus target
Current Price $191.14
Consensus Target $225.47
Bull Target $284.0
Bear Target $195.0
Analysts Covering 19
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
13
Hold
2
Sell
1
52-Week Low $154.5
52-Week High $247.05
YTD Return -15.2%
FUNDAMENTALS
Market Cap $32B
P/E Ratio (TTM) 23.7x
Forward P/E 13.5x
EPS (TTM) $8.05
PEG Ratio 0.75
Dividend Yield N/A
Revenue (TTM) $16.6B
Profit Margin 8.3%
52-WEEK RANGE
52-Week Low $154.5
52-Week High $247.05
Current Price $191.14
Bear Target $195.0
Bull Target $284.0
● Now $191.14 ● Target $225.47
TRADING DATA
Avg Volume 1.7M
YTD Return -15.2%
Analyst Count 19
Consensus Buy
Upside to Target +18.0%
Last Updated 2026-06-27

ANALYST SUMMARY

IQVIA Holdings Inc. (IQV) is currently trading at $191.14 with a Wall Street consensus price target of $225.47, implying potential upside of 18.0% over the next 12 months. 19 analysts currently cover IQV, with a consensus rating of Buy - 84% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $284.0, while the most cautious has a target of $195.0.

IQV operates in the Healthcare sector with a market capitalisation of $32B. The stock is down 15.2% year-to-date and is currently trading near the lower end of its 52-week range of $154.5 – $247.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for IQV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley ↓ Downgrade
Overweight → Equal-Weight 2026-06-17 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-04-08 Building track record
TD Cowen ↑ Upgrade
Hold → Buy 2026-03-09 Building track record
Barclays ↑ Upgrade
Equal-Weight → Overweight 2026-03-06 Building track record
RBC Capital ● Initiated
Outperform 2026-03-03 Building track record
Truist Securities — Reiterated
Buy → Buy 2026-02-19 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-02-06 43% win rate (7 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-02-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
66
out of 100
Coverage depth
23/30
Consensus clarity
21/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →